Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Impact · against what's priced in

Merit Medical (MMSI) reported a strong Q2 beat on both top and bottom lines, with EPS and revenue exceeding consensus estimates. This performance indicates organic demand and improving profitability, serving as a positive catalyst for the stock.

MMSI+0.60

No priced-in read yet

In context

The company reported a significant EPS beat of $1.19 versus the $0.96 estimate and revenue of $418.84 million, which exceeded the consensus of $404.67 million.

Read from the article alone

• healthcare▲13%
• earnings▲3%
• revenue
• MMSI
• eps
• financial results
• medical devices

Top 2 movers · tap to explore